Diabetes technology

Real-World Data from U.S. Commercial Users of the 365-Day Implantable Eversense Continuous Glucose Monitoring System, Including with the Twiist Automated Insulin Delivery System Integration

Diabetes Technol TherPublished Retrospective real-world observational study

Authors' conclusion

In this large real-world dataset, the 365-day CGM system demonstrated high adherence and favorable glucometrics sustained over extended wear.

Study context

Population
U.S. commercial users of the 365-day implantable Eversense Continuous Glucose Monitoring (CGM) system; open-loop mean age 57 years
Exposure
Eversense 365 CGM with open-loop therapies; twiist + Eversense 365 automated insulin delivery (AID) system
  • Open-loopn = 12,360 sensors
  • Twiist + Eversense 365 AIDn = 153 sensors
Outcome
Glucometrics with Eversense 365 CGM in open-loop therapy
Follow-up
365-day wear
Methodological detailsdeidentified data, Eversense Data Management System
  • Deidentified data
  • Eversense Data Management System

Main finding

As reported in the abstract

Mean sensor glucose (SG)
161 mg/dL
Glucose management indicator (GMI)
7.16%
Mean % time <54 mg/dL
0.6%
Mean % time <70 mg/dL
2.7%
Mean % TIR 70-180 mg/dL
66.2%
Mean % time >180 mg/dL
31.2%
Mean % time >250 mg/dL
9.8%
Median transmitter wear time
93%

Observational data: associations, not effects.

Further findings

CGM readings per sensor (open-loop)

Mean CGM readings per sensor (±SD)
43,225 (±32,394)

Glycemic outcomes, first vs second 180-day period (open-loop) · first and second 180-day periods

Glycemic outcomes remained stable across the first and second 180-day periods

Glucometrics with twiist + Eversense 365 AID system · >30 days following twiist pairing

Mean SG
145 mg/dL
GMI
6.78%
TIR
76.1%
% time <70 mg/dL
2.3%
% time <54 mg/dL
0.5%
Median transmitter wear time
99%
  • 153 sensors

Original publication

Real-World Data from U.S. Commercial Users of the 365-Day Implantable Eversense Continuous Glucose Monitoring System, Including with the Twiist Automated Insulin Delivery System Integration. Diabetes Technol Ther. Published 8 September 2026. doi:10.1177/15209156261486125

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.